Harrold, L., Litman, H., Saunders, K., Dandreo, K., Gershenson, B., Greenberg, J., … Yassine, M. (2018). One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry. Arthritis Research & Therapy, 20(1), 2. https://doi.org/10.1186/s13075-017-1496-5 (Original work published 2018)